The c13 urea breath test is to detect Helicobacter pylori. H. pylori is a common disease, and its infection is a high-risk factor for inducing gastric cancer, gastric ulcers and other diseases. Long-term exposure of the organism to the infection is prone to induce diseases of the cardiovascular system, skeletal system and other diseases. C13 Breath test is an easy and rapid method to detect it, which has the advantages of non-invasive and rapid screening compared with histopathological detection and other means. Fasting should be maintained during the test. In the clinical treatment of H. pylori infection, antibiotic drugs and proton pump inhibitors are commonly used therapeutic drugs. In the process of clinical application, amoxicillin, clarithromycin, rabeprazole and colloidal bismuth pectin are selected as therapeutic drugs for anti-inflammatory and bacterial removal, and at the same time to achieve the effect of inhibition of gastric acid secretion and gastric mucosa protection. Under the joint action of drugs, the pathogenic factors are effectively eliminated. If you use the drug, please use it under the guidance of a pharmacist or physician.